NCT00930696

Brief Summary

Surgical treatment of deep endometriosis with bowel involvement is widely accepted to require complete excision of all endometriosis also when invading the bowel. In case of opening of the bowel a subsequent inflammatory reaction follows the surgery, as demonstrated by the increase in blood levels of C-reactive protein during the first post-operative week. Furthermore it increases the risk of post-operative bowel complications. In case of peritonitis the general surgeons use extensive lavage in order to decreases mortality, morbidity and post-operative adhesions formation, as demonstrated in animal models and clinically in patients with peritonitis. Considering the efficacy of extensive lavage for peritonitis and the inflammatory reaction as judged by the increased C-reactive protein (CRP) following full thickness deep endometriosis resection from the bowel, the study aims to evaluate, in women undergoing this procedure, the effect of extensive abdominal lavage on abdominal inflammation and post-operative bowel complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started May 2005

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2007

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

June 26, 2009

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 30, 2009

Completed
Last Updated

June 30, 2009

Status Verified

June 1, 2009

Enrollment Period

1.7 years

First QC Date

June 26, 2009

Last Update Submit

June 29, 2009

Conditions

Keywords

endometriosisabdominal lavagebowel perforationdiscoid resectionlaparoscopy

Outcome Measures

Primary Outcomes (1)

  • Post-operative C-reactive protein blood values

    Daily for 1 week

Secondary Outcomes (1)

  • Bowel complications rate

    By the clinicians during the first post-operative week and at 1 and 6 months

Study Arms (2)

Extensive Abdominal Lavage

EXPERIMENTAL

women with full thickness excision of deep endometriosis involving the bowel

Procedure: Extensive abdominal lavage

Standard Rinsing

ACTIVE COMPARATOR

women with full thickness excision of deep endometriosis involving the bowel

Procedure: Rinsing of the abdomen

Interventions

Extensive lavage of the abdomen with 8 liters of saline at the end of the surgical procedure

Extensive Abdominal Lavage

Standard rinsing of the abdomen with some 0,5 liters of saline at the end of the surgical procedure

Standard Rinsing

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • The patients (aged 18-50 years) were all recruited from a single, tertiary referral hospital at Leuven University, Belgium, specializing in the surgical treatment of severe endometriosis.
  • All the women were scheduled for a surgical excision of a rectovaginal nodule.
  • Women with a full thickness involvement of the bowel requiring discoid resection were included.

You may not qualify if:

  • evidence on chest x-ray in the previous 3 months of old or currently active TB, even if adequately treated;
  • evidence of serious infections (such as pneumonia or pyelonephritis) in the previous 3 months
  • evidence of a documented HIV infection, active hepatitis-B or C, or an opportunistic infection (e.g. herpes zoster, cytomegalovirus, pneumocystis carinii, aspergillosis, histoplasmosis, or mycobacteria other than TB) in the previous 6 months
  • Previous transplant surgery, a lymphoproliferative disorder or other malignancy
  • Positive cervical cytology in the previous 6 months
  • Any haematological or biochemical abnormalities on routine screening.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Gasthuisberg

Leuven, 3000, Belgium

Location

Related Publications (6)

  • Adam U, Ledwon D, Hopt UT. [Programmed lavage as a basic principle in therapy of diffuse peritonitis]. Langenbecks Arch Chir. 1997;382(4 Suppl 1):S18-21. doi: 10.1007/pl00014638. German.

    PMID: 9333702BACKGROUND
  • Arnesjo B, Breland U, Petersson BG. The effect of peritoneal lavage on the postoperative course after colonic anastomosis and perforation in the rat. Acta Chir Scand. 1975;141(5):433-6.

    PMID: 1181805BACKGROUND
  • Koninckx PR, Timmermans B, Meuleman C, Penninckx F. Complications of CO2-laser endoscopic excision of deep endometriosis. Hum Reprod. 1996 Oct;11(10):2263-8. doi: 10.1093/oxfordjournals.humrep.a019087.

    PMID: 8943540BACKGROUND
  • Polubinska A, Winckiewicz M, Staniszewski R, Breborowicz A, Oreopoulos DG. Time to reconsider saline as the ideal rinsing solution during abdominal surgery. Am J Surg. 2006 Sep;192(3):281-5. doi: 10.1016/j.amjsurg.2005.05.047.

    PMID: 16920418BACKGROUND
  • Ret Davalos ML, De Cicco C, D'Hoore A, De Decker B, Koninckx PR. Outcome after rectum or sigmoid resection: a review for gynecologists. J Minim Invasive Gynecol. 2007 Jan-Feb;14(1):33-8. doi: 10.1016/j.jmig.2006.07.015.

    PMID: 17218226BACKGROUND
  • Sortini D, Feo CV, Maravegias K, Carcoforo P, Pozza E, Liboni A, Sortini A. Role of peritoneal lavage in adhesion formation and survival rate in rats: an experimental study. J Invest Surg. 2006 Sep-Oct;19(5):291-7. doi: 10.1080/08941930600889409.

    PMID: 16966207BACKGROUND

MeSH Terms

Conditions

EndometriosisIntestinal Perforation

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Philippe R Koninckx, MD, PhD

    Catholic University Leuven

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 26, 2009

First Posted

June 30, 2009

Study Start

May 1, 2005

Primary Completion

January 1, 2007

Study Completion

January 1, 2007

Last Updated

June 30, 2009

Record last verified: 2009-06

Locations